Home > Drug Search >
  • company_query: BioAegis
  •   > 
Drug Filter
Category:
chemistry (8) biology (18)
Status:
Approved (2) Phase Ⅲ (5) Phase Ⅱ (11) Phase Ⅰ (8)
Clinical Stage:
Pending (5) Active (18) Discontinued (1)
Bio-Type:
Gene therapy (4) Vaccine (8) Recombinant cytokines (1) Other recombinant protein (1) Whole antibody (2)
Indication:
Advanced renal cell carcinoma (RCC) (1) Atopic dermatitis (1) Breast cancer (2) Community-acquired pneumonia (CAP) (1) Metachromatic leukodystrophy (1) Cystic fibrosis (CF) (1) Neuronal ceroid lipofuscinoses (1) Bronchitis (1) Cytomegalovirus infections (1) Hyperlipidemia (1) Insomnia (1) Rabies (1) Melanoma (1) Neuropathic pain (1) Non small cell lung cancer (NSCLC) (2) Pancreatic cancer (2) Parkinson's disease (PD) (1) Peptic ulcer (1) Prostate cancer (1) Renal cell carcinoma (1) Rheumatoid arthritis (RA) (2) Colorectal cancer (3) Systemic inflammatory response syndrome (SIRS) (1) Hemophilia B (1) Septic shock (1) Glioblastoma (2) Advanced melanoma (1) Bleeding (1) Diffuse large B cell lymphoma (1) Bacterial infection (1)
Country:
Aprv. Year:
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top